Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Torrent Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:500420NSE Symbol: TORNTPHARMP/E(TTM):61.28
ISIN Demat:INE685A01028Div & Yield %:0.85EPS(TTM):53.9
Book Value(Rs):222.3860114Market Cap ( Cr.):111776.74Face Value(Rs):5
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 8532.907695.206742.326450.576168.445762.48
Excise Duty0.000.000.000.000.000.00
Net Sales8532.907695.206742.326450.576168.445762.48
Other Income 91.3681.88204.17118.34236.93381.96
Stock Adjustments 68.61-128.4418.34150.1456.834.97
Total Income8692.877648.646964.836719.056462.206149.41
EXPENDITURE :      
Raw Materials 2200.392010.981925.841819.811694.281549.71
Power & Fuel Cost143.43153.21140.00122.04126.70131.49
Employee Cost 1450.671251.221097.931097.121061.761014.06
Other Manufacturing Expenses 173.82143.39141.56136.19130.43153.12
Selling and Administration Expenses 1254.381138.57954.66851.08918.63903.86
Miscellaneous Expenses 489.52404.23399.91382.74376.48402.18
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure5712.215101.604659.904408.984308.284154.42
Operating Profit2980.662547.042304.932310.072153.921994.99
Interest 303.04297.68236.29334.12430.49480.97
Gross Profit2677.622249.362068.641975.951723.431514.02
Depreciation761.05672.34602.43609.84606.66578.90
Profit Before Tax1916.571577.021466.211366.111116.77935.12
Tax321.67274.20253.27247.77192.13193.75
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax237.82251.43221.49-19.51-13.87-4.05
Reported Net Profit1357.081051.39991.451137.85938.51745.42
Extraordinary Items 14.8827.976.8612.7524.1831.09
Adjusted Net Profit1342.201023.42984.591125.10914.33714.33
Adjst. below Net Profit 0.44-7.07-1.557.21-120.06-10.07
P & L Balance brought forward3394.213212.922899.912093.301884.051453.31
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 1015.34863.03676.89338.45609.20304.61
P & L Balance carried down3736.393394.213212.922899.912093.301884.05
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %560.00440.00960.00700.00640.00340.00
Earnings Per Share-Unit Curr40.1031.0658.5867.2355.4544.05
Earnings Per Share(Adj)-Unit Curr40.1031.0629.2933.6227.7322.03
Book Value-Unit Curr201.76190.75374.94356.30302.59296.34